GFACX
Price
$57.16
Change
-$3.41 (-5.63%)
Updated
Apr 3 closing price
Net Assets
279.82B
RGACX
Price
$64.60
Change
-$3.86 (-5.64%)
Updated
Apr 3 closing price
Net Assets
279.82B
Ad is loading...

GFACX vs RGACX

Header iconGFACX vs RGACX Comparison
Open Charts GFACX vs RGACXBanner chart's image
American Funds Growth Fund of Amer C
Price$57.16
Change-$3.41 (-5.63%)
VolumeN/A
Net Assets279.82B
American Funds Growth Fund of Amer R3
Price$64.60
Change-$3.86 (-5.64%)
VolumeN/A
Net Assets279.82B
GFACX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. RGACX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and RGACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX (280B) and RGACX (280B) have equal amount of cash in the bank . RGACX pays higher dividends than GFACX: RGACX (0.09) vs GFACX (0.00). GFACX was incepted earlier than RGACX: GFACX (24 years) vs RGACX (23 years). GFACX (1.36) is less costly to investors than RGACX (0.94). GFACX (25.00) and RGACX (25.00) have comparable annual turnover. GFACX (250) and RGACX (250) have matching initial minimum investment requirements. RGACX annual gain was more profitable for investors over the last year : -0.32 vs. GFACX (-1.75). RGACX return over 5 years is better than : 68.49 vs. GFACX (59.73).
GFACXRGACXGFACX / RGACX
Total Expense Ratio1.360.94145%
Annual Report Gross Expense Ratio1.360.94145%
Fund Existence24 years23 years-
Gain YTD-5.003-4.903102%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets280B280B100%
Annual Yield % from dividends0.000.09-
Returns for 1 year-1.75-0.32555%
Returns for 3 years0.634.1515%
Returns for 5 years59.7368.4987%
Returns for 10 years44.4657.4177%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLY9.54-0.41
-4.12%
Oatly Group AB
INDP0.47-0.03
-5.24%
Indaptus Therapeutics
VTRS8.16-0.50
-5.77%
Viatris
GDRX4.29-0.28
-6.13%
GoodRx Holdings
KOD2.40-0.27
-10.11%
Kodiak Sciences